Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1078

1.

Associations among particulate matter, hazardous air pollutants and methane emissions from the Aliso Canyon natural gas storage facility during the 2015 blowout.

Garcia-Gonzales DA, Popoola O, Bright VB, Paulson SE, Wang Y, Jones RL, Jerrett M.

Environ Int. 2019 Jun 18:104855. doi: 10.1016/j.envint.2019.05.049. [Epub ahead of print]

2.

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1.

Somaiah N, Block MS, Kim JW, Shapiro GI, Do KT, Hwu P, Eder JP, Jones RL, Lu H, Ter Meulen J, Bohac C, Chen M, Hsu FJ, Gnjatic S, Pollack SM.

Clin Cancer Res. 2019 Jun 21. pii: clincanres.1025.2019. doi: 10.1158/1078-0432.CCR-19-1025. [Epub ahead of print]

PMID:
31227504
3.

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).

Sanfilippo R, Jones RL, Blay JY, Le Cesne A, Provenzano S, Antoniou G, Mir O, Fucà G, Fumagalli E, Bertulli R, Stacchiotti S, Brahmi M, Grosso F, Dufresne A, Hindi N, Sbaraglia M, Gronchi A, Collini P, Dei Tos AP, Casali PG.

Clin Cancer Res. 2019 Jun 19. doi: 10.1158/1078-0432.CCR-19-0288. [Epub ahead of print]

PMID:
31217199
4.

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.

Berlow NE, Rikhi R, Geltzeiler M, Abraham J, Svalina MN, Davis LE, Wise E, Mancini M, Noujaim J, Mansoor A, Quist MJ, Matlock KL, Goros MW, Hernandez BS, Doung YC, Thway K, Tsukahara T, Nishio J, Huang ET, Airhart S, Bult CJ, Gandour-Edwards R, Maki RG, Jones RL, Michalek JE, Milovancev M, Ghosh S, Pal R, Keller C.

BMC Cancer. 2019 Jun 17;19(1):593. doi: 10.1186/s12885-019-5681-6.

5.

Molecular partitioning in ternary solutions of cellulose.

Zhang X, Mao Y, Tyagi M, Jiang F, Henderson D, Jiang B, Lin Z, Jones RL, Hu L, Briber RM, Wang H.

Carbohydr Polym. 2019 Sep 15;220:157-162. doi: 10.1016/j.carbpol.2019.05.054. Epub 2019 May 23.

PMID:
31196535
6.

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.

Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, Pillarisetty VG, Cranmer LD, Van Tine BA, Yee C, Pierce RH, Riddell SR, Jones RL, Pollack SM.

Cancer Immunol Res. 2019 Jun 6. doi: 10.1158/2326-6066.CIR-18-0940. [Epub ahead of print]

PMID:
31171504
7.

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

Younger E, Ballman K, Lu Y, Pápai Z, Van Tine BA, Attia S, Schöffski P, Reinke D, Tap WD, Jones RL.

J Geriatr Oncol. 2019 May 21. pii: S1879-4068(18)30464-8. doi: 10.1016/j.jgo.2019.05.008. [Epub ahead of print]

8.

Pazopanib in advanced soft tissue sarcomas.

Lee ATJ, Jones RL, Huang PH.

Signal Transduct Target Ther. 2019 May 17;4:16. doi: 10.1038/s41392-019-0049-6. eCollection 2019. Review.

9.

Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review.

Scott RE, Greenwood SL, Hayes DJL, Baker BC, Jones RL, Heazell AEP.

Reprod Toxicol. 2019 Aug;87:50-59. doi: 10.1016/j.reprotox.2019.05.056. Epub 2019 May 10.

PMID:
31082466
10.

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

Jones RL, Chawla SP, Attia S, Schöffski P, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG.

Cancer. 2019 Jul 15;125(14):2445-2454. doi: 10.1002/cncr.32084. Epub 2019 Apr 29.

PMID:
31034598
11.

Correction.

Brook A, Hoaksey A, Gurung R, Yoong EEC, Sneyd R, Baynes GC, Bischof H, Jones S, Higgins LE, Jones C, Greenwood SL, Jones RL, Gram M, Lang I, Desoye G, Myers J, Schneider H, Hansson SR, Crocker IP, Brownbill P.

FASEB J. 2019 May;33(5):6682. doi: 10.1096/fj.201800264RERR. No abstract available.

PMID:
31034282
12.

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Chamberlain FE, Wilding C, Jones RL, Huang P.

Expert Opin Investig Drugs. 2019 Jun;28(6):505-511. doi: 10.1080/13543784.2019.1607291. Epub 2019 Apr 22. Review.

PMID:
31010343
13.

Bisexual Lives and Aging in Context: A Cross-National Comparison of the United Kingdom and the United States.

Jen S, Jones RL.

Int J Aging Hum Dev. 2019 Jul;89(1):22-38. doi: 10.1177/0091415019843661. Epub 2019 Apr 18. No abstract available.

PMID:
30997826
14.

Failure of Decidualization and Maternal Immune Tolerance Underlies Uterovascular Resistance in Intra Uterine Growth Restriction.

Dunk C, Kwan M, Hazan A, Walker S, Wright JK, Harris LK, Jones RL, Keating S, Kingdom JCP, Whittle W, Maxwell C, Lye SJ.

Front Endocrinol (Lausanne). 2019 Mar 20;10:160. doi: 10.3389/fendo.2019.00160. eCollection 2019.

15.

Aldoxorubicin in soft tissue sarcomas.

Chamberlain FE, Jones RL, Chawla SP.

Future Oncol. 2019 May;15(13):1429-1435. doi: 10.2217/fon-2018-0922. Epub 2019 Mar 15.

PMID:
30873850
16.

Differential effect of LPS and IL-1β in term placental explants.

Duval C, Brien ME, Gaudreault V, Boufaied I, Baker B, Jones RL, Girard S.

Placenta. 2019 Jan;75:9-15. doi: 10.1016/j.placenta.2018.11.006. Epub 2018 Nov 22.

PMID:
30712669
17.

Treatment of Desmoid Tumors in 2019.

Gronchi A, Jones RL.

JAMA Oncol. 2019 Jan 31. doi: 10.1001/jamaoncol.2018.6449. [Epub ahead of print] No abstract available.

PMID:
30703188
18.

Use of a Mouse Model of Experimentally Induced Endometriosis to Evaluate and Compare the Effects of Bisphenol A and Bisphenol AF Exposure.

Jones RL, Lang SA, Kendziorski JA, Greene AD, Burns KA.

Environ Health Perspect. 2018 Dec;126(12):127004. doi: 10.1289/EHP3802.

19.

Very low-level prenatal mercury exposure and behaviors in children: the HOME Study.

Patel NB, Xu Y, McCandless LC, Chen A, Yolton K, Braun J, Jones RL, Dietrich KN, Lanphear BP.

Environ Health. 2019 Jan 9;18(1):4. doi: 10.1186/s12940-018-0443-5.

20.

Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients.

Sebio A, Constantinidou A, Benson C, Antoniou G, Messiou C, Miah A, Zaidi S, Petruckevitch A, Al-Muderis O, Thway K, VAN DER Graaf WT, Jones RL.

Anticancer Res. 2019 Jan;39(1):347-351. doi: 10.21873/anticanres.13118.

PMID:
30591479
21.

Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck.

Hahn E, Huang SH, Hosni A, Razak AA, Jones RL, Dickson BC, Sturgis EM, Patel SG, O'Sullivan B.

Clin Transl Radiat Oncol. 2018 Nov 27;15:13-19. doi: 10.1016/j.ctro.2018.11.009. eCollection 2019 Feb. Review.

22.

Optimising Cancer Vaccine Design in Sarcoma.

Pender A, Jones RL, Pollack S.

Cancers (Basel). 2018 Dec 20;11(1). pii: E1. doi: 10.3390/cancers11010001. Review.

23.

LAMP: A CDC Program to Ensure the Quality of Blood-Lead Laboratory Measurements.

Caldwell KL, Cheng PY, Vance KA, Makhmudov A, Jarrett JM, Caudill SP, Ho DP, Jones RL.

J Public Health Manag Pract. 2019 Jan/Feb;25 Suppl 1, Lead Poisoning Prevention:S23-S30. doi: 10.1097/PHH.0000000000000886.

PMID:
30507766
24.

Alarmins at the maternal-fetal interface: involvement of inflammation in placental dysfunction and pregnancy complications 1.

Brien ME, Baker B, Duval C, Gaudreault V, Jones RL, Girard S.

Can J Physiol Pharmacol. 2019 Mar;97(3):206-212. doi: 10.1139/cjpp-2018-0363. Epub 2018 Nov 28. Review.

PMID:
30485131
25.

Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma.

Jones RL, Mo G, Baldwin JR, Peterson PM, Ilaria RL Jr, Conti I, Cronier DM, Tap WD.

Cancer Chemother Pharmacol. 2019 Jan;83(1):191-199. doi: 10.1007/s00280-018-3723-4. Epub 2018 Nov 8.

26.

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review.

Riedel RF, Jones RL, Italiano A, Bohac C, Thompson JC, Mueller K, Khan Z, Pollack SM, Van Tine BA.

Cancers (Basel). 2018 Nov 1;10(11). pii: E417. doi: 10.3390/cancers10110417. Review.

27.

Age-related sarcoma patient experience: results from a national survey in England.

Younger E, Husson O, Bennister L, Whelan J, Wilson R, Roast A, Jones RL, van der Graaf WT.

BMC Cancer. 2018 Oct 17;18(1):991. doi: 10.1186/s12885-018-4866-8.

28.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee, PaedCan and ERN EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv79-iv95. doi: 10.1093/annonc/mdy310. No abstract available.

29.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv268-iv269. doi: 10.1093/annonc/mdy321. No abstract available.

30.

Decidual leucocytes infiltrating human spiral arterioles are rich source of matrix metalloproteinases and degrade extracellular matrix in vitro and in situ.

Choudhury RH, Dunk CE, Lye SJ, Harris LK, Aplin JD, Jones RL.

Am J Reprod Immunol. 2019 Jan;81(1):e13054. doi: 10.1111/aji.13054. Epub 2018 Sep 29.

PMID:
30267451
31.

Trends in Modern Phase 1 Oncology Trials.

Jones RL.

N Engl J Med. 2018 Sep 20;379(12):1188-9. doi: 10.1056/NEJMc1808907. No abstract available.

PMID:
30260158
32.

Pregnancy outcome in mothers over the age of 35.

Heazell AEP, Newman L, Lean SC, Jones RL.

Curr Opin Obstet Gynecol. 2018 Dec;30(6):337-343. doi: 10.1097/GCO.0000000000000494.

PMID:
30239372
33.

Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.

Jones RL, Le Cesne A, Ibrahim T, Garcia Del Muro X, Menge F.

Expert Rev Anticancer Ther. 2018 Dec;18(12):1241-1248. doi: 10.1080/14737140.2018.1524298. Epub 2018 Sep 26. Review.

PMID:
30220224
34.

Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.

Owen C, Constantinidou A, Miah AB, Thway K, Fisher C, Benson C, Zaidi S, Messiou C, VAN DER Graaf WTA, Jones RL.

Anticancer Res. 2018 Sep;38(9):5275-5282. doi: 10.21873/anticanres.12853. Review.

PMID:
30194178
35.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv267. doi: 10.1093/annonc/mdy320. No abstract available.

36.

Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma.

Chew W, Benson C, Thway K, Hayes A, Miah A, Zaidi S, Lee ATJ, Messiou C, Fisher C, van der Graaf WT, Jones RL.

Med Oncol. 2018 Sep 5;35(11):138. doi: 10.1007/s12032-018-1192-6.

37.

US CENTERS FOR DISEASE CONTROL AND PREVENTION EXPERIENCE IN THE JOINT EXTERNAL EVALUATION PROCESS-RADIATION EMERGENCIES TECHNICAL AREA.

Whitcomb RC Jr, Ansari AJ, Salame-Alfie A, McCurley MC, Buzzell J, Chang A, Jones RL.

Radiat Prot Dosimetry. 2018 Dec 1;182(1):9-13. doi: 10.1093/rpd/ncy148.

PMID:
30165684
38.

Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?

Husson O, Younger E, Dunlop A, Dean L, Strauss DC, Benson C, Hayes AJ, Miah A, van Houdt W, Zaidi S, Smith M, Williams J, Jones RL, van der Graaf WTA.

Support Care Cancer. 2019 Mar;27(3):965-980. doi: 10.1007/s00520-018-4386-8. Epub 2018 Aug 28.

39.

Developing a Relative Humidity Correction for Low-Cost Sensors Measuring Ambient Particulate Matter.

Di Antonio A, Popoola OAM, Ouyang B, Saffell J, Jones RL.

Sensors (Basel). 2018 Aug 24;18(9). pii: E2790. doi: 10.3390/s18092790.

40.

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.

Pender A, Davis EJ, Chauhan D, Messiou C, Al-Muderis O, Thway K, Fisher C, Zaidi S, Miah A, Judson I, van der Graaf W, Keedy VL, Benson C, Jones RL.

Med Oncol. 2018 Aug 20;35(10):131. doi: 10.1007/s12032-018-1193-5.

41.

Characterization of Interfacial Structure in Polymer-Fullerene Bulk Heterojunctions via ^{13}C {^{2}H} Rotational Echo Double Resonance NMR.

Nieuwendaal RC, DeLongchamp DM, Richter LJ, Snyder CR, Jones RL, Engmann S, Herzing A, Heeney M, Fei Z, Sieval AB, Hummelen JC.

Phys Rev Lett. 2018 Jul 13;121(2):026101. doi: 10.1103/PhysRevLett.121.026101.

42.

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Jones RL, Demetri GD, Schuetze SM, Milhem M, Elias A, Van Tine BA, Hamm J, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Patel S, von Mehren M.

Ann Oncol. 2018 Sep 1;29(9):1995-2002. doi: 10.1093/annonc/mdy253.

PMID:
30084934
43.

Aggregation and Solubility of a Model Conjugated Donor-Acceptor Polymer.

Reid DR, Jackson NE, Bourque AJ, Snyder CR, Jones RL, de Pablo JJ.

J Phys Chem Lett. 2018 Aug 16;9(16):4802-4807. doi: 10.1021/acs.jpclett.8b01738. Epub 2018 Aug 9.

PMID:
30063357
44.

2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.

Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG.

ESMO Open. 2018 Jun 28;3(4):e000390. doi: 10.1136/esmoopen-2018-000390. eCollection 2018. Review.

45.

Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation.

Hallin M, Miki Y, Hayes AJ, Jones RL, Fisher C, Thway K.

Rare Tumors. 2018 Jun 20;10:2036361318782626. doi: 10.1177/2036361318782626. eCollection 2018.

46.

Pancreaticoduodenectomy for the Management of Pancreatic or Duodenal Metastases from Primary Sarcoma.

Huddy JR, Sodergren MH, Deguara J, Thway K, Jones RL, Mudan SS.

Anticancer Res. 2018 Jul;38(7):4041-4046. doi: 10.21873/anticanres.12693.

PMID:
29970529
47.

Measuring Aerosol Phase Changes and Hygroscopicity with a Microresonator Mass Sensor.

Zielinski AT, Gallimore PJ, Griffiths PT, Jones RL, Seshia AA, Kalberer M.

Anal Chem. 2018 Aug 21;90(16):9716-9724. doi: 10.1021/acs.analchem.8b00114. Epub 2018 Jul 31.

PMID:
29969232
48.

Assessing the stability of Cd, Mn, Pb, Se, and total Hg in whole human blood by ICP-DRC-MS as a function of temperature and time.

Tevis DS, Jarrett JM, Jones DR, Cheng PY, Franklin M, Mullinex N, Caldwell KL, Jones RL.

Clin Chim Acta. 2018 Oct;485:1-6. doi: 10.1016/j.cca.2018.05.043. Epub 2018 Jun 9.

PMID:
29894782
49.

The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.

Gronchi A, Jones RL.

JAMA Oncol. 2018 Sep 1;4(9):1167-1168. doi: 10.1001/jamaoncol.2018.1392. No abstract available.

PMID:
29879269
50.

Viscoplastic fracture transition of a biopolymer gel.

Frieberg BR, Garatsa RS, Jones RL, Bachert JO, Crawshaw B, Liu XM, Chan EP.

Soft Matter. 2018 Jun 13;14(23):4696-4701. doi: 10.1039/c8sm00722e.

PMID:
29856452

Supplemental Content

Loading ...
Support Center